Skip to main content

Advertisement

Articles

Page 4 of 47

  1. Clinically, distant metastasis after primary treatment remains a key problem in nasopharyngeal carcinoma (NPC). Thus, identification of the underlying mechanisms and development of novel therapeutic strategies...

    Authors: You Zou, Rui Yang, Mao-Ling Huang, Yong-Gang Kong, Jian-Fei Sheng, Ze-Zhang Tao, Ling Gao and Shi-Ming Chen

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:456

    Content type: Research

    Published on:

  2. The regulatory non-coding RNAs, including long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), emerge as pivotal markers during tumor progression. Abnormal sialylated glycoprotein often leads to the malignan...

    Authors: Bing Liu, Qianqian Liu, Shimeng Pan, Yiran Huang, Yu Qi, Shuangda Li, Yang Xiao and Li Jia

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:455

    Content type: Research

    Published on:

  3. Limited effective intervention for advanced hepatocellular carcinoma (HCC) is available. This study aimed to investigate the potential clinical utility of apatinib, a highly selective inhibitor of the vascular...

    Authors: Junbin Liao, Huilin Jin, Shaoqiang Li, Lixia Xu, Zhenwei Peng, Guangyan Wei, Jianting Long, Yu Guo, Ming Kuang, Qi Zhou and Sui Peng

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:454

    Content type: Research

    Published on:

  4. The first line therapy for patients with diffuse large B cell (DLBCL) is R-CHOP. About half of DLBCL patients are either refractory to, or will relapse, after the treatment. Therefore, identifying novel drug t...

    Authors: Liling Jiang, Yuening Sun, Jinxiang Wang, Qingyan He, Xinmei Chen, Xiaoying Lan, Jinghong Chen, Q. Ping Dou, Xianping Shi and Jinbao Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:453

    Content type: Research

    Published on:

  5. Increasing evidence shows that stimulated by retinoic acid 6 (STRA6) participates in regulating multiple cancers. However, the biological roles of STRA6 in gastric cancer (GC) remain unknown. This study aimed ...

    Authors: Linling Lin, Jian Xiao, Liang Shi, Wangwang Chen, Yugang Ge, Mingkun Jiang, Zengliang Li, Hao Fan, Li Yang and Zekuan Xu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:452

    Content type: Research

    Published on:

  6. In the original publication of this article [1], Fig. 3 is wrong, but does not affect discussions and conclusions drawn in the article.

    Authors: Yuyuan Yao, Qinglong Guo, Yue Cao, Yangmin Qiu, Renxiang Tan, Zhou Yu, Yuxin Zhou and Na Lu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:451

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:282

  7. Diffuse large B-cell lymphomas (DLBCLs) are aggressive lymphomas accounting for approximately a third of non-Hodgkin lymphomas. Prohibitin 1 (PHB1) and prohibitin 2 (PHB2) are scaffold proteins that promote mi...

    Authors: Hafidha Bentayeb, Marine Aitamer, Barbara Petit, Lydie Dubanet, Sabria Elderwish, Laurent Désaubry, Armand de Gramont, Eric Raymond, Agnès Olivrie, Julie Abraham, Marie-Odile Jauberteau and Danielle Troutaud

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:450

    Content type: Research

    Published on:

  8. Interleukin-8 (IL-8) plays a vital role in the invasion and metastasis of hepatocellular carcinoma (HCC), and is closely associated with poor prognosis of HCC patients. Integrin αvβ3, a member of the integrin ...

    Authors: Fengkai Sun, Jianping Wang, Qi Sun, Fanni Li, Hengjun Gao, Lin Xu, Jiao Zhang, Xiaoyan Sun, Yanan Tian, Qiujie Zhao, Huimin Shen, Kai Zhang and Jun Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:449

    Content type: Research

    Published on:

  9. A natural compound Jaspine B and its derivative possess potential anti-cancer activities; However, little is known about the underlying mechanism. Here, the role of a new autophagy inducer Jaspine B derivative...

    Authors: Haiyang Yu, Chun-Li Wu, Xiangyu Wang, Qianhong Ban, Chunhua Quan, Mengbo Liu, Hangqi Dong, Jinfeng Li, Gi-Young Kim, Yung Hyun Choi, Zhenya Wang and Cheng-Yun Jin

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:448

    Content type: Research

    Published on:

  10. Molecular targeted therapy for advanced hepatocellular carcinoma (HCC) has changed markedly. Although sorafenib was used in clinical practice as the first molecular targeted agent in 2007, the SHARPE and Asian...

    Authors: Ziyu Liu, Yan Lin, Jinyan Zhang, Yumei Zhang, Yongqiang Li, Zhihui Liu, Qian Li, Ming Luo, Rong Liang and Jiazhou Ye

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:447

    Content type: Review

    Published on:

  11. NOTCH1 gene mutations in mantle cell lymphoma (MCL) have been described in about 5–10% of cases and are associated with significantly shorter survival rates. The present study aimed to investigate the biological ...

    Authors: Elisabeth Silkenstedt, Fabian Arenas, Berta Colom-Sanmartí, Sílvia Xargay-Torrent, Morihiro Higashi, Ariadna Giró, Vanina Rodriguez, Patricia Fuentes, Walter E. Aulitzky, Heiko van der Kuip, Sílvia Beà, Maria L. Toribio, Elias Campo, Mònica López-Guerra and Dolors Colomer

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:446

    Content type: Research

    Published on:

  12. In the publication of our publication [1], we have noticed there is a wrong label in Fig. 1e, in which the position of “HCC” and “Adjacent” should be transposed.

    Authors: Wuhua Zhou, Li Gong, Qinchuan Wu, Chunyang Xing, Bajin Wei, Tianchi Chen, Yuan Zhou, Shengyong Yin, Bin Jiang, Haiyang Xie, Lin Zhou and Shusen Zheng

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:445

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:215

  13. In the original publication of this article [1], there are mistakes in Fig. 3c and Fig. 3e.

    Authors: Yuyuan Yao, Kai Zhao, Zhou Yu, Haochuan Ren, Li Zhao, Zhiyu Li, Qinglong Guo and Na Lu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:444

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2017 36:103

  14. In the original publication of this article [1], the author would like to revise Figure 4.

    Authors: Meng-Xuan Zhu, Chuan-Yuan Wei, Peng-Fei Zhang, Dong-Mei Gao, Jie Chen, Yan Zhao, Shuang-Shuang Dong and Bin-Bin Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:443

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:409

  15. In the original publication of this article [1], the indicated stages (I-II III-IV) were missing in the clinical stage part at both Table 1 and Table 2.

    Authors: Kai Teng, Shi Wei, Chi Zhang, Jiewei Chen, Jinbin Chen, Kanghua Xiao, Jun Liu, Miaomiao Dai, Xinyuan Guan, Jingping Yun and Dan Xie

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:442

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:329

  16. In the original publication of this article,[1] the Funding section needs to be revised, and the corrected Funding section appears below.

    Authors: Morvarid Saeinasab, Ahmad Reza Bahrami, Jovanna González, Francesco P. Marchese, Dannys Martinez, Seyed Javad Mowla, Maryam M. Matin and Maite Huarte

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:441

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:172

  17. In the original publication of this article [1], there are mistakes in Fig. 4d. The corrected Fig. 4 should be:

    Authors: Sahyun Pak, Sejun Park, Yunlim Kim, Jung-Hyuck Park, Chan-Hee Park, Kyoung-June Lee, Choung-soo Kim and Hanjong Ahn

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:440

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:342

  18. ERp57 dysfunction has been shown to contribute to tumorigenesis in multiple malignances. However, the role of ERp57 in clear cell renal carcinoma (ccRCC) remains unclear.

    Authors: Yan Liu, Jian-Xing Wang, Zi-Yuan Nie, Yue Wen, Xin-Ju Jia, Li-Na Zhang, Hui-Jun Duan and Yong-Hong Shi

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:439

    Content type: Research

    Published on:

  19. Glutathione S-transferase zeta 1 (GSTZ1) is the penultimate enzyme in phenylalanine/tyrosine catabolism. GSTZ1 is dysregulated in cancers; however, its role in tumorigenesis and progression of hepatocellular c...

    Authors: Jingjing Li, Qiujie Wang, Yi Yang, Chong Lei, Fan Yang, Li Liang, Chang Chen, Jie Xia, Kai Wang and Ni Tang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:438

    Content type: Research

    Published on:

  20. All-trans-retinoic-acid (ATRA) is a promising agent in the prevention/treatment of breast-cancer. There is growing evidence that reprogramming of cellular lipid metabolism contributes to malignant transformati...

    Authors: Mineko Terao, Laura Goracci, Valentina Celestini, Mami Kurosaki, Marco Bolis, Alessandra Di Veroli, Arianna Vallerga, Maddalena Fratelli, Monica Lupi, Alessandro Corbelli, Fabio Fiordaliso, Maurizio Gianni, Gabriela Paroni, Adriana Zanetti, Gabriele Cruciani and Enrico Garattini

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:436

    Content type: Research

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2019 38:496

  21. Our previous work demonstrated that lncRNA-MALAT1 was overexpressed in recurrent colorectal cancer (CRC) and metastatic sites in post-surgical patients. However, the upstream regulatory mechanism of MALAT1 is ...

    Authors: Xinnan Wu, Ruixiao Li, Qing Song, Chengcheng Zhang, Ru Jia, Zhifen Han, Lihong Zhou, Hua Sui, Xuan Liu, Huirong Zhu, Liu Yang, Yan Wang, Qing Ji and Qi Li

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:435

    Content type: Research

    Published on:

  22. Breast cancer (BC) is the most frequent malignant tumor in females and the 2nd most common cause of brain metastasis (BM), that are associated with a fatal prognosis. The increasing incidence from 10% up to 40...

    Authors: Simon Bernatz, Elena I. Ilina, Kavi Devraj, Patrick N. Harter, Klaus Mueller, Sascha Kleber, Yannick Braun, Cornelia Penski, Christoph Renner, Rashi Halder, Lukas Jennewein, Christine Solbach, Frits Thorsen, Bernhard C. Pestalozzi, Axel Mischo and Michel Mittelbronn

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:434

    Content type: Research

    Published on:

  23. Bladder cancer (BC) is a common urothelial malignancy, characterized by a high recurrence rate. The biology of bladder cancer is complex and needs to be deciphered. The latest evidence reveals the critical rol...

    Authors: Cornelia Braicu, Rares Buiga, Roxana Cojocneanu, Mihail Buse, Lajos Raduly, Laura Ancuta Pop, Sergiu Chira, Liviuta Budisan, Ancuta Jurj, Cristina Ciocan, Lorand Magdo, Alexandru Irimie, Florentin Dobrota, Bogdan Petrut and Ioana Berindan-Neagoe

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:433

    Content type: Research

    Published on:

  24. Inefficient T-cell access to the tumor microenvironment (TME) is among the causes of tumor immune-resistance. Previous evidence demonstrated that targeting CXCR4 improves anti-PD-1/PD-L1 efficacy reshaping TME...

    Authors: Crescenzo D’Alterio, Maria Buoncervello, Caterina Ieranò, Maria Napolitano, Luigi Portella, Giuseppina Rea, Antonio Barbieri, Antonio Luciano, Giosuè Scognamiglio, Fabiana Tatangelo, Anna Maria Anniciello, Mario Monaco, Ernesta Cavalcanti, Piera Maiolino, Giulia Romagnoli, Claudio Arra…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:432

    Content type: Research

    Published on:

  25. Pancreatic cancer is one of the most lethal malignancies due to frequent late diagnosis, aggressive tumor growth and metastasis formation. Continuously raising incidence rates of pancreatic cancer and a lack o...

    Authors: Claudia M. Kowolik, Min Lin, Jun Xie, Larry E. Overman and David A. Horne

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:431

    Content type: Research

    Published on:

  26. miR-133a-3p has been recently discovered to be down-regulated in various human malignancies, including breast cancer, and reduced miR-133a-3p levels have been significantly associated with breast cancer cell g...

    Authors: Wanyue Shi, Tingting Tang, Xinping Li, Siwei Deng, Ruiyi Li, Yingshan Wang, Yifei Wang, Tiansong Xia, Yanfeng Zhang, Ke Zen, Liang Jin and Yi Pan

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:429

    Content type: Research

    Published on:

  27. BMP3 gene is often found hypermethylated and hence inactivated in several types of cancers including colorectal cancer (CRC), indicating that it has a suppressor role in carcinogenesis. Though BMP3 is a reliab...

    Authors: Jialing Wen, Xianglin Liu, Yan Qi, Feng Niu, Zhitong Niu, Wenjing Geng, Zhaowei Zou, Renli Huang, Jianping Wang and Hongzhi Zou

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:428

    Content type: Research

    Published on:

  28. A promising strategy to overcome the chemoresistance is the tumor blood vessel normalization, which restores the physiological perfusion and oxygenation of tumor vasculature. Thalidomide (Thal) has been shown ...

    Authors: Yanwei Shen, Shuting Li, Xin Wang, Mengying Wang, Qi Tian, Jiao Yang, Jichang Wang, Biyuan Wang, Peijun Liu and Jin Yang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:427

    Content type: Research

    Published on:

  29. Polo-like kinase 3 (PLK3) has been documented as a tumor suppressor in several types of malignancies. However, the role of PLK3 in colorectal cancer (CRC) progression and glucose metabolism remains to be known.

    Authors: Baochi Ou, Hongze Sun, Jingkun Zhao, Zhuoqing Xu, Yuan Liu, Hao Feng and Zhihai Peng

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:426

    Content type: Research

    Published on:

  30. In the original publication of this article, [1] the affiliation for Katia Scotlandi needs to be revised, because the author prefers using its Italian name: Experimental Oncology Lab, Experimental Oncology Lab...

    Authors: Claudia Chiodoni, Maria Teresa Di Martino, Francesca Zazzeroni, Michele Caraglia, Massimo Donadelli, Stefania Meschini, Carlo Leonetti and Katia Scotlandi

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:425

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:128

  31. Merkel cell carcinomas (MCCs) are rare, aggressive, therapeutically-challenging skin tumours that are increasing in incidence and have poor survival rates. The majority are caused by genomic Merkel cell polyom...

    Authors: Lucia Cappabianca, Stefano Guadagni, Rita Maccarone, Michela Sebastiano, Alessandro Chiominto, Antonietta Rosella Farina and Andrew Reay Mackay

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:424

    Content type: Research

    Published on:

  32. Galectins are beta-galactose specific binding proteins. In human cancers, including hepatocellular carcinoma (HCC), galectin-1 (Gal-1) is often found to be overexpressed. In order to combat the dismal diagnosi...

    Authors: Zoe Leung, Frankie Chi Fat Ko, Sze Keong Tey, Ernest Man Lok Kwong, Xiaowen Mao, Bonnie Hei Man Liu, Angel Po Yee Ma, Yi Man Eva Fung, Chi-Ming Che, Danny Ka Ho Wong, Ching Lung Lai, Irene Oi-Lin Ng and Judy Wai Ping Yam

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:423

    Content type: Research

    Published on:

  33. Cancer-initiating cell (CIC), a functionally homogeneous stem-like cell population, is resonsible for driving the tumor maintenance and metastasis, and is a source of chemotherapy and radiation-therapy resista...

    Authors: Jinhua Wang, Yajing Xing, Yingying Wang, Yundong He, Liting Wang, Shihong Peng, Lianfang Yang, Jiuqing Xie, Xiaotao Li, Wenwei Qiu, Zhengfang Yi and Mingyao Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:422

    Content type: Research

    Published on:

  34. The monocyte chemoattractant protein-induced protein (MCPIP) family consists of 4 members (MCPIP1–4) encoded by the ZC3h12A-D genes, which are located at different loci. The common features of MCPIP proteins are ...

    Authors: Katarzyna Miekus, Jerzy Kotlinowski, Agata Lichawska-Cieslar, Janusz Rys and Jolanta Jura

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:421

    Content type: Review

    Published on:

  35. Glioblastoma is the most common and aggressive brain tumour in adults with a median overall survival of only 14 months after standard therapy with radiation therapy (IR) and temozolomide (TMZ). In a novel mult...

    Authors: Ina Patties, Sonja Kallendrusch, Lisa Böhme, Eva Kendzia, Henry Oppermann, Frank Gaunitz, Rolf-Dieter Kortmann and Annegret Glasow

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:420

    Content type: Research

    Published on:

  36. Until very few years ago, the oncology community dogmatically excluded any clinical potential for immunotherapy in controlling brain metastases. Therefore, despite the significant therapeutic efficacy of monoc...

    Authors: Anna Maria Di Giacomo, Monica Valente, Alfonso Cerase, Maria Fortunata Lofiego, Francesca Piazzini, Luana Calabrò, Elisabetta Gambale, Alessia Covre and Michele Maio

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:419

    Content type: Review

    Published on:

  37. An increasing number of studies have shown that long noncoding RNAs (lncRNAs) play essential roles in tumor initiation and progression. LncRNAs act as tumor promoters or suppressors by targeting specific genes...

    Authors: Kun Qiao, Shipeng Ning, Lin Wan, Hao Wu, Qin Wang, Xingda Zhang, Shouping Xu and Da Pang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:418

    Content type: Research

    Published on:

  38. MEIS2 has been identified as one of the key transcription factors in the gene regulatory network in the development and pathogenesis of human cancers. Our study aims to identify the regulatory mechanisms of ME...

    Authors: Lei Guan, Ting Li, Nanping Ai, Wei Wang, Bing He, Yanxia Bai, Zhaocai Yu, Mingyue Li, Shanshan Dong, Qingge Zhu, Xiao Xiao Ding, Shiming Zhang, Ming li, Guangbo Tang, Xiaochun Xia, Jing Zhao…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:417

    Content type: Research

    Published on:

  39. At the beginning of tumorigenesis, newly born cancer cells must successfully avoid attack by the immune system. Although most abnormal cells are efficiently identified and destroyed by the immune system, parti...

    Authors: Kotaro Saga, Jinhee Park, Keisuke Nimura, Norihiko Kawamura, Airi Ishibashi, Norio Nonomura and Yasufumi Kaneda

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:416

    Content type: Research

    Published on:

  40. In the original publication of this manuscript [1], Fig. 5E lower panel was incorrect due to an error in the preparation of these figures for publication. It was noticed that in the lower panel of Fig. 5E, one...

    Authors: Huiling Lai, Xuejiao Zhao, Yu Qin, Yi Ding, Ruqi Chen, Guannan Li, Marilyne Labrie, Zhiyong Ding, Jianfeng Zhou, Junbo Hu, Ding Ma, Yong Fang and Qinglei Gao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:415

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:32

  41. Tamoxifen resistance presents a huge clinical challenge for breast cancer patients. An understanding of the mechanisms of tamoxifen resistance can guide development of efficient therapies to prevent drug resis...

    Authors: Fujun Li, Lixia Miao, Teng Xue, Hao Qin, Santanu Mondal, Paul R. Thompson, Scott A. Coonrod, Xiaoqiu Liu and Xuesen Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:414

    Content type: Research

    Published on:

  42. CyclinD1 is crucial for cell cycling and can regulate the expression of Dicer, a crucial regulator of microRNA maturation. However, little is known on how CyclinD1 regulates Dicer and miRNA expression, and the...

    Authors: Yongqiang Qi, Da Wang, Wenhua Huang, Bing Wang, Di Huang, Fei Xiong, Xiaoping Chen and Yongjun Chen

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:413

    Content type: Research

    Published on:

  43. The transcription factor HOXD9 is one of the members of the HOX family, which plays an important role in neoplastic processes. However, the role of HOXD9 in the growth and metastasis of gastric cancer (GC) rem...

    Authors: Huiqiong Zhu, Weiyu Dai, Jiaying Li, Li Xiang, Xiaosheng Wu, Weimei Tang, Yaying Chen, Qiong Yang, Mengwei Liu, Yizhi Xiao, Wenjing Zhang, Jianjiao Lin, Jing Wang, Guangnan Liu, Yong Sun, Ping Jiang…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:412

    Content type: Research

    Published on:

  44. Long non-coding RNA (lncRNA) HOXA transcript at the distal tip (HOTTIP), has been demonstrated to be a vital biomarker when evaluating the prognosis of multiple cancers. Nevertheless, the potential function of...

    Authors: Anquan Shang, Weiwei Wang, Chenzheng Gu, Chen Chen, Bingjie Zeng, Yibao Yang, Ping Ji, Junjun Sun, Junlu Wu, Wenying Lu, Zujun Sun and Dong Li

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:411

    Content type: Research

    Published on:

  45. UFM1 has been found to be involved in the regulation of tumor development. This study aims to clarify the role and potential molecular mechanisms of UFM1 in the invasion and metastasis of gastric cancer.

    Authors: Jian-Xian Lin, Xin-Sheng Xie, Xiong-Feng Weng, Sheng-Liang Qiu, Changhwan Yoon, Ning-Zi Lian, Jian-Wei Xie, Jia-Bin Wang, Jun Lu, Qi-Yue Chen, Long-Long Cao, Mi Lin, Ru-Hong Tu, Ying-Hong Yang, Chang-Ming Huang, Chao-Hui Zheng…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:410

    Content type: Research

    Published on:

  46. ATPase associated with a variety of cellular activities (AAA ATPase) family members are closely linked to tumor formation and progression. However, their roles in hepatocellular carcinoma (HCC) largely remain ...

    Authors: Meng-Xuan Zhu, Chuan-Yuan Wei, Peng-Fei Zhang, Dong-Mei Gao, Jie Chen, Yan Zhao, Shuang-Shuang Dong and Bin-Bin Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:409

    Content type: Research

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2019 38:443

  47. Replication-competent oncolytic viruses (OVs) have been proven to be a potent anticancer weapon for clinical therapy. The preexisting neutralizing antibody in patients is a big challenge for oncolytic efficacy...

    Authors: Mao Xia, Dongjun Luo, Jie Dong, Meihong Zheng, Gang Meng, Junhua Wu and Jiwu Wei

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:408

    Content type: Research

    Published on:

  48. In the publication of this article [1], there are two corrections.

    Authors: Ming Tan, Qian Zhang, Xiaohong Yuan, Yuanzhong Chen and Yong Wu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:407

    Content type: Correction

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:308

Annual Journal Metrics

Advertisement